CY1110449T1 - Συνδυασμος δοκεταξελης και φλαβοπιριδinολης - Google Patents
Συνδυασμος δοκεταξελης και φλαβοπιριδinοληςInfo
- Publication number
- CY1110449T1 CY1110449T1 CY20081100843T CY081100843T CY1110449T1 CY 1110449 T1 CY1110449 T1 CY 1110449T1 CY 20081100843 T CY20081100843 T CY 20081100843T CY 081100843 T CY081100843 T CY 081100843T CY 1110449 T1 CY1110449 T1 CY 1110449T1
- Authority
- CY
- Cyprus
- Prior art keywords
- flavopyridinol
- docetaxel
- combination
- dependent kinase
- cyclin dependent
- Prior art date
Links
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 title abstract 2
- 229960003668 docetaxel Drugs 0.000 title 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 2
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 2
- 229940123237 Taxane Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
- RCINICONZNJXQF-XAZOAEDWSA-N taxol® Chemical compound O([C@@H]1[C@@]2(CC(C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3(C21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-XAZOAEDWSA-N 0.000 abstract 1
- 229940063683 taxotere Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27794801P | 2001-03-23 | 2001-03-23 | |
| US30269201P | 2001-07-05 | 2001-07-05 | |
| US33491601P | 2001-12-04 | 2001-12-04 | |
| EP02737950A EP1372652B1 (en) | 2001-03-23 | 2002-03-22 | Combination of docetaxel and flavopiridol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110449T1 true CY1110449T1 (el) | 2015-04-29 |
Family
ID=27402954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100843T CY1110449T1 (el) | 2001-03-23 | 2008-08-11 | Συνδυασμος δοκεταξελης και φλαβοπιριδinολης |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20020182204A1 (OSRAM) |
| EP (1) | EP1372652B1 (OSRAM) |
| JP (1) | JP2004521140A (OSRAM) |
| KR (1) | KR100879712B1 (OSRAM) |
| CN (1) | CN1498107A (OSRAM) |
| AR (1) | AR034222A1 (OSRAM) |
| AT (1) | ATE395917T1 (OSRAM) |
| AU (1) | AU2002312815B2 (OSRAM) |
| BR (1) | BR0208221A (OSRAM) |
| CA (1) | CA2441441C (OSRAM) |
| CY (1) | CY1110449T1 (OSRAM) |
| CZ (1) | CZ301423B6 (OSRAM) |
| DE (1) | DE60226710D1 (OSRAM) |
| DK (1) | DK1372652T3 (OSRAM) |
| EA (1) | EA007815B1 (OSRAM) |
| ES (1) | ES2305253T3 (OSRAM) |
| HR (1) | HRPK20030766B3 (OSRAM) |
| HU (1) | HU229258B1 (OSRAM) |
| IL (2) | IL158058A0 (OSRAM) |
| ME (1) | MEP16408A (OSRAM) |
| MX (1) | MXPA03007743A (OSRAM) |
| NO (1) | NO332441B1 (OSRAM) |
| NZ (1) | NZ527655A (OSRAM) |
| PE (1) | PE20020907A1 (OSRAM) |
| PL (1) | PL206118B1 (OSRAM) |
| PT (1) | PT1372652E (OSRAM) |
| RS (1) | RS50681B (OSRAM) |
| SI (1) | SI1372652T1 (OSRAM) |
| SK (1) | SK287481B6 (OSRAM) |
| TW (1) | TWI355935B (OSRAM) |
| UY (1) | UY27220A1 (OSRAM) |
| WO (1) | WO2002076484A2 (OSRAM) |
| ZA (1) | ZA200307381B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487434B1 (en) * | 2002-03-06 | 2007-05-09 | The Medical Research and Education Trust | Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| WO2004035034A2 (en) * | 2002-10-16 | 2004-04-29 | Ilex Products, Inc. | Clofarabine and taxane chemotherapy combination |
| AU2003276467A1 (en) * | 2002-11-06 | 2004-06-07 | Cyclacel Limited | Combination comprising docetaxel and a cdk inhibitor |
| AU2007213791A1 (en) * | 2006-02-10 | 2007-08-16 | Nerviano Medical Sciences S.R.L. | Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| AU2011330733A1 (en) * | 2010-11-19 | 2013-06-06 | Piramal Enterprises Limited | Pharmaceutical combination of paclitaxel and a CDK inhibitor |
| ME03589B (me) | 2011-04-01 | 2020-07-20 | Astrazeneca Ab | Terapeutski tretman |
| PT2785349T (pt) | 2011-11-30 | 2019-12-11 | Astrazeneca Ab | Tratamento combinado de cancro |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| AU2195297A (en) * | 1996-02-20 | 1997-09-02 | Sloan-Kettering Institute For Cancer Research | Combinations of pkc inhibitors and therapeutic agents for treating cancers |
-
2002
- 2002-03-21 UY UY27220A patent/UY27220A1/es not_active Application Discontinuation
- 2002-03-21 US US10/101,947 patent/US20020182204A1/en not_active Abandoned
- 2002-03-22 PT PT02737950T patent/PT1372652E/pt unknown
- 2002-03-22 HR HR20030766A patent/HRPK20030766B3/xx not_active IP Right Cessation
- 2002-03-22 PL PL367702A patent/PL206118B1/pl not_active IP Right Cessation
- 2002-03-22 JP JP2002574997A patent/JP2004521140A/ja active Pending
- 2002-03-22 AU AU2002312815A patent/AU2002312815B2/en not_active Ceased
- 2002-03-22 NZ NZ527655A patent/NZ527655A/xx not_active IP Right Cessation
- 2002-03-22 IL IL15805802A patent/IL158058A0/xx unknown
- 2002-03-22 EP EP02737950A patent/EP1372652B1/en not_active Expired - Lifetime
- 2002-03-22 SK SK1169-2003A patent/SK287481B6/sk not_active IP Right Cessation
- 2002-03-22 CA CA002441441A patent/CA2441441C/en not_active Expired - Fee Related
- 2002-03-22 CZ CZ20032551A patent/CZ301423B6/cs not_active IP Right Cessation
- 2002-03-22 BR BR0208221-7A patent/BR0208221A/pt not_active Application Discontinuation
- 2002-03-22 ES ES02737950T patent/ES2305253T3/es not_active Expired - Lifetime
- 2002-03-22 DE DE60226710T patent/DE60226710D1/de not_active Expired - Lifetime
- 2002-03-22 ME MEP-164/08A patent/MEP16408A/xx unknown
- 2002-03-22 WO PCT/EP2002/004083 patent/WO2002076484A2/en not_active Ceased
- 2002-03-22 CN CNA028070380A patent/CN1498107A/zh active Pending
- 2002-03-22 HU HU0303589A patent/HU229258B1/hu not_active IP Right Cessation
- 2002-03-22 AR ARP020101061A patent/AR034222A1/es unknown
- 2002-03-22 PE PE2002000230A patent/PE20020907A1/es not_active Application Discontinuation
- 2002-03-22 AT AT02737950T patent/ATE395917T1/de active
- 2002-03-22 DK DK02737950T patent/DK1372652T3/da active
- 2002-03-22 MX MXPA03007743A patent/MXPA03007743A/es active IP Right Grant
- 2002-03-22 TW TW091105567A patent/TWI355935B/zh not_active IP Right Cessation
- 2002-03-22 KR KR1020037012338A patent/KR100879712B1/ko not_active Expired - Fee Related
- 2002-03-22 RS YUP-695/03A patent/RS50681B/sr unknown
- 2002-03-22 EA EA200301053A patent/EA007815B1/ru not_active IP Right Cessation
- 2002-03-22 SI SI200230711T patent/SI1372652T1/sl unknown
-
2003
- 2003-09-16 NO NO20034124A patent/NO332441B1/no not_active IP Right Cessation
- 2003-09-22 IL IL158058A patent/IL158058A/en not_active IP Right Cessation
- 2003-09-22 ZA ZA2003/07381A patent/ZA200307381B/en unknown
-
2006
- 2006-01-27 US US11/341,840 patent/US20060128640A1/en not_active Abandoned
-
2008
- 2008-08-11 CY CY20081100843T patent/CY1110449T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110449T1 (el) | Συνδυασμος δοκεταξελης και φλαβοπιριδinολης | |
| CY1105690T1 (el) | Μεθοδοι και σκευασματα για χορηγηση ταξανιων | |
| DK1061915T3 (da) | Farmaceutiske formuleringer af taxaner | |
| DE60203260D1 (de) | Pharmazeutische mischung gegen krebs, die ein 4-chinazolinamin in kombination mit paclitaxel, carboplatin or vinorelbine enthält | |
| CY1109681T1 (el) | Υποκατεστημενα παραγωγα κιναζολινης ως αναστολεις των κινασων aurora | |
| CY2014008I2 (el) | Παραγωγα κιναζολινης, φαρμακα που περιεχουν τις ενωσεις αυτες, χρηση αυτων και μεθοδους για την παραγωγη τους | |
| UY27175A1 (es) | Nueva sal succinato de o-desmetil- venlafaxina | |
| SE0302811D0 (sv) | Novel compounds | |
| TW200716206A (en) | Unitary pharmaceutical dosage form | |
| CL2004000930A1 (es) | Compuesto derivado de dihidroquinazolina de formula definida, util para el tratamiento y/o profilaxis de infecciones virales; composicion farmaceutica que comprende al compuesto y uso del compuesto en la preparacion de medicamentos. | |
| DE60209929D1 (de) | Succinate des 5,8,14-triazatetracycloä10.3.1.0 2,11 .0 4,9 ü-hexadeca-2(11),3,5,7,9,-pentaens und pharmazeutische zusammensetzungen | |
| CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
| EP1379508A4 (en) | N- (ARYL) -2-ARYLETHESULFONAMIDES AND THEIR THERAPEUTIC APPLICATIONS | |
| BRPI0515721A (pt) | uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação | |
| EP1503748A4 (en) | DRUGS TO REDUCE TAXAN-INDUCED NEUROTOXICITY | |
| DE60134414D1 (de) | 4-pyrimidinamine derivate, pharmazeutische zusammenstellungen und verwandte methoden | |
| DE60327323D1 (de) | Chinazoline derivative und ihre anwendung in der krebsbehandlung | |
| DE69815100D1 (de) | Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten | |
| WO2002078690A3 (en) | Taxoid anti-tumor agents and pharmaceutical compositions thereof | |
| EP1845099A4 (en) | ARTEMISIN- (QINGHAOSU-) DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF | |
| HRP20080597T3 (en) | Cancer combination therapy comprising azd2171 and zd1839 | |
| DE60032372D1 (de) | Arzneizubereitungen enthaltend paclitaxel eingeschlossen in nanopartikeln von polymerischen mizellen | |
| CY1106964T1 (el) | Φαρμακα που περιεχουν ν,ν’-διυποκατεστημενες ενωσεις πιπεραζινης και η χρησιμοποιηση τους | |
| ATE402719T1 (de) | Injiziebare pharmazeutische zusammensetzung enthaltend ethanol zur behandlung von bandscheibenvorfällen | |
| CY1112717T1 (el) | Παραγωγα διαρυλμεθυλ πιπεραζινης, παρασκευες αυτων και χρησεις αυτων |